rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
162	Hyperlipidemia, combined, 1	C0020473	19	293	1.07793907134e-09	4.256437204414084e-05	CYP3A4,APOA4,HP,NPHS1,F7,CYP2C19,APOC1,CYP2C8,APOC3,SLC25A13,APOA2,APOC2,ALB,APOA1,APOE,CDCP1,CYP2C9,SLC10A1,ABCB1
163	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	7	28	1.45460876677e-09	4.282711508145034e-05	KRT10,KRT14,KRT5,KRT9,FN1,KRT1,GFAP
164	Palmar hyperkeratosis	C0240641	7	28	1.45460876677e-09	4.3089858118759854e-05	KRT10,KRT14,KRT5,KRT16,KRT9,KRT6A,KRT1
166	Plantar hyperkeratosis	C1856954	7	32	4.46492487427e-09	4.361534419337888e-05	KRT10,KRT14,KRT5,KRT16,KRT9,KRT6A,KRT1
169	Kidney Diseases	C0022658	30	755	7.93275756195e-09	4.4403573305307404e-05	SLC22A2,CYP3A4,APOA4,HP,NPHS1,CST3,AHSG,SLC22A12,F7,CTSL,CYP2C8,APOC3,ABCC2,ABCC3,FN1,SLC22A8,GSN,CFH,ALB,ATM,RYR2,TTR,APOA1,SLC22A6,APOE,CYP2C9,ABCC11,ABCB1,ABCC4,ADRA1B
170	Acute kidney injury	C0022660	17	270	1.03296351472e-08	4.466631634261692e-05	SLC22A2,CYP3A4,HP,CST3,SLC22A12,CYP2C19,SLC22A1,FN1,SLC22A8,CFH,ALB,ATM,CFB,SLC22A6,APOE,CYP2C9,ABCB1
173	Intrahepatic cholestasis	C0008372	8	60	5.62867695786e-08	4.545454545454546e-05	SLC22A2,SLC22A1,ABCC2,ABCC3,SLC25A13,APOE,SLC10A1,ABCC4
174	Palmoplantar keratoderma, nonepidermolytic, focal	C0022596	12	156	8.95988574445e-08	4.571728849185497e-05	KRT10,KRT14,KRT5,KRT16,SCN5A,KRT9,TTN,DMD,KRT6A,LDB3,KRT1,KRT6B
176	Cholecystolithiasis	C0947622	9	86	1.2368506308e-07	4.6242774566473984e-05	APOA4,SLCO1A2,APOC1,APOC3,ABCC3,TTR,APOA1,APOE,FABP6
179	Myofibrillar myopathy, BAG3-related	C2678065	6	34	1.79746320605e-07	4.7031003678402524e-05	TTN,DMD,FN1,GSN,CFH,LDB3
180	Familial type 3 hyperlipoproteinemia	C0020479	6	34	1.79746320605e-07	4.729374671571204e-05	CYP3A4,APOC1,APOC3,APOC2,APOA1,APOE
182	Diabetes mellitus type 2	C0011860	51	1972	2.37255772695e-07	4.7819232790331056e-05	SLC22A2,CYP3A4,APOA4,HP,ABCC5,ABCC6,NPHS1,SLCO1A2,TSC22D1,CST3,KRT16,AHSG,SLC22A12,F7,SCN5A,CTSL,CYP2C19,APOC1,MGST3,SLC22A1,CYP2C8,APOC3,ABCC2,APOA2,DMD,TOMM40,GRAP2,APOC2,DICER1,FN1,ITGA2,DGKG,HPX,GSN,THRAP3,CFH,ALB,PEG3,ATM,CRB1,TTR,CFB,APOA1,APOE,CYP2C9,CAMTA1,FABP6,ABCC11,ABCB1,DCD,ST13
183	Kidney Failure, Chronic	C0022661	24	616	2.92364404797e-07	4.8081975827640565e-05	SLC22A2,CYP3A4,HP,NPHS1,CST3,AHSG,F7,CYP2C19,CYP2C8,APOC3,ABCC2,ABCC3,KLK3,ITGA2,GSN,CFH,ALB,ATM,TTR,APOA1,APOE,CYP2C9,ABCB1,ADRA1B
184	Drug Resistant Epilepsy	C1096063	7	53	2.96698692615e-07	4.834471886495008e-05	CYP2C19,ABCC2,ALB,APOE,ABCC1,ABCB1,GFAP
192	Abnormality of the plantar skin of foot	C4020946	7	57	5.29658426784e-07	5.044666316342617e-05	KRT10,KRT14,KRT5,KRT16,KRT9,KRT6A,KRT1
194	Hyperlipoproteinemia	C0020476	6	43	9.77472406238e-07	5.097214923804519e-05	APOC3,APOA2,APOC2,ALB,APOA1,APOE
195	Hyperkeratosis	C0870082	14	258	1.00816057158e-06	5.12348922753547e-05	KRT10,KRT14,KRT5,KRT16,SCN5A,APOC1,KRT9,KRT13,TTN,DMD,KRT6A,LDB3,KRT1,KRT6B
196	Hypertriglyceridemia result	C1522137	6	44	1.1500287459e-06	5.149763531266422e-05	APOA4,APOC3,APOA2,APOC2,APOA1,APOE
199	Hippocampal sclerosis	C1504404	6	45	1.34734589208e-06	5.228586442459275e-05	GABBR1,SLC16A1,APOE,ABCC1,ABCB1,GFAP
200	Old myocardial infarction	C0155668	5	29	1.35612579932e-06	5.254860746190226e-05	APOA4,CYP2C8,APOA1,APOE,CYP2C9
201	cardiac event	C0741923	6	46	1.57229754583e-06	5.281135049921177e-05	HP,SCN5A,CYP2C19,SLC22A5,RYR2,ABCB1
208	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	C0740394	7	69	2.35316903074e-06	5.465055176037835e-05	SLC22A2,APOA4,SLC22A12,APOC3,APOA1,APOE,SLC22A11
209	Cerebral Amyloid Angiopathy	C0085220	6	50	2.81118273082e-06	5.491329479768786e-05	CST3,GSN,TTR,APOA1,APOE,ABCB1
213	Acute Coronary Syndrome	C0948089	15	320	3.15963918429e-06	5.5964266946925903e-05	CYP3A4,SLCO1A2,CST3,F7,CYP2C19,APOC3,ITGA2,PPBP,GSN,ALB,ATM,APOA1,APOE,CYP2C9,ABCB1
214	Coronary heart disease 7	C0010054	25	754	3.5021992898e-06	5.622700998423542e-05	CYP3A4,APOA4,HP,ABCC6,CST3,AHSG,F7,SCN5A,CYP2C19,APOC1,CYP2C8,APOC3,TTN,APOA2,FN1,ITGA2,PF4V1,CFH,ALB,SLC22A5,ATM,APOA1,APOE,CYP2C9,ABCB1
215	Acute myocardial ischemia	C0151744	19	484	3.53525397923e-06	5.648975302154493e-05	CYP3A4,APOA4,ABCC6,F7,SCN5A,CYP2C19,APOC3,TTN,DMD,ITGA2,CFH,ALB,ATM,PDE4B,RYR2,APOA1,APOE,CYP2C9,ABCB1
216	Abnormal blistering of the skin	C2132198	7	74	4.01820166795e-06	5.675249605885444e-05	KRT10,KRT14,KRT5,KRT16,KRT6A,KRT1,KRT6B
221	Primary biliary cirrhosis	C0008312	13	263	6.42226923586e-06	5.8066211245402e-05	CYP3A4,ABCC5,ABCC6,SLC22A1,ABCC2,ABCC3,ALB,ATM,APOE,ABCC1,SLC10A1,ABCB1,ABCC4
222	Hyperhidrosis	C0020458	8	104	6.45755919115e-06	5.832895428271151e-05	KRT14,KRT5,KRT16,KRT9,NLRC4,KRT6A,KRT1,KRT6B
224	Chronic kidney disease	C1561643	15	342	7.33535993991e-06	5.885444035733054e-05	SLC22A2,APOA4,HP,CST3,AHSG,CYP2C19,CYP2C8,TOMM40,FN1,ITGA2,CFH,ALB,ATM,APOE,ABCB1
238	Epidermal thickening	C0494876	14	309	9.14179918388e-06	6.253284287966369e-05	CHKB,KRT10,KRT14,KRT5,KRT16,SCN5A,KRT9,KRT13,TTN,DMD,KRT6A,LDB3,KRT1,KRT6B
239	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	34	1262	9.44198793174e-06	6.279558591697321e-05	SERPING1,ABCC6,KRT10,KRT14,KRT5,CST3,KRT16,SCN5A,KRT9,KRT13,KCNMA1,TTN,GJC2,DICER1,PLAG1,FN1,ITGA2,NLRC4,GSN,CFH,SETX,AP4E1,SLC16A1,LDB3,RYR2,TTR,APOA1,APOE,SPAST,CYP2C9,CAMTA1,KRT1,KRT6B,GFAP
240	Neurotoxicity Syndromes	C0235032	5	40	9.76114514406e-06	6.305832895428271e-05	LAT,CYP2C19,CYP2C9,ABCB1,ADRA1B
241	Adverse drug events and drug allergies	C0041755	6	60	9.76811965059e-06	6.332107199159222e-05	ABCC2,ALB,ABCC1,CYP2C9,ABCB1,ABCC4
242	Dermal atrophy	C0151514	12	237	9.97284601112e-06	6.358381502890173e-05	ABCC6,KRT14,KRT5,APOC1,TTN,KLK3,CFH,SETX,CRB1,APOE,CYP2C9,ABCC11
246	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	24	756	1.1087842112e-05	6.463478717813977e-05	SERPING1,CYP3A4,ABCC5,ABCC6,CYP2C8,ABCC2,SACS,ABCC3,GJC2,SLC22A8,TLN2,NLRC4,GSN,SLC22A5,SETX,LDB3,ATM,TTR,APOE,ABCC1,SPAST,ABCB1,ABCC4,GFAP
247	Drug Eruptions	C0011609	4	25	1.2789981614e-05	6.489753021544929e-05	APOC3,APOC2,TTR,APOA1
248	Chromosome 11p deletion syndrome	C0812435	4	25	1.2789981614e-05	6.51602732527588e-05	ABCC2,SLC22A8,SLC22A6,ABCC4
249	Bleeding disorder, platelet-type, 21	C0005779	10	177	1.51602630983e-05	6.542301629006832e-05	ABCC6,F7,CYP2C19,CYP2C8,KLK3,GSN,ALB,APOE,CYP2C9,ABCB1
250	Renal Insufficiency, Chronic	C0035078	15	363	1.53626112387e-05	6.568575932737784e-05	SLC22A2,HP,NPHS1,CST3,CYP2C19,ABCC2,KLK3,CFH,ALB,ATM,SLC22A6,APOE,SLC22A11,ABCB1,ABCC4
251	Hypercholesterolemia, autosomal dominant, type B	C0020443	11	212	1.59979445598e-05	6.594850236468734e-05	CYP3A4,APOA4,CYP2C19,APOC3,SLC25A13,APOA2,ALB,APOA1,APOE,CYP2C9,ABCB1
252	Myopathy, scapulohumeroperoneal	C0026848	17	450	1.68571071587e-05	6.621124540199684e-05	CHKB,CYP3A4,OBSL1,TRAPPC11,SCN5A,CYP2C8,TTN,DMD,CFH,ALB,SLC22A5,LDB3,RYR2,TTR,APOE,CYP2C9,GFAP
253	Nephrotic Syndrome, Minimal Change	C1704321	5	44	1.72133179784e-05	6.647398843930635e-05	NPHS1,HPX,ALB,APOE,ABCB1
254	Thromboembolism	C0040038	8	118	1.80404244798e-05	6.673673147661587e-05	CYP3A4,APOA4,F7,CYP2C19,ITGA2,CFH,ATM,CYP2C9
255	Vascular Diseases	C0042373	16	410	1.83361586252e-05	6.699947451392539e-05	HP,ABCC6,CST3,AHSG,F7,APOC3,DMD,ITGA2,PF4V1,ALB,ATM,TTR,APOA1,APOE,CYP2C9,ABCC4
260	Skin Diseases, Genetic	C0037277	5	46	2.23665374e-05	6.831318970047294e-05	KRT10,KRT14,KRT5,KRT9,KRT1
261	Ichthyosis, congenital, autosomal recessive 12	C0020757	9	152	2.2662203455e-05	6.857593273778245e-05	CHKB,KRT10,KRT14,KRT16,KRT9,DMD,KRT6A,KRT1,KRT6B
262	Restenosis	C0333186	11	220	2.31060681714e-05	6.883867577509197e-05	SERPING1,APOA4,HP,F7,CYP2C19,APOC3,ITGA2,ALB,ATM,APOE,ABCC11
263	Chronic Kidney Insufficiency	C0403447	10	186	2.4062299011e-05	6.910141881240148e-05	APOA4,HP,CST3,AHSG,CYP2C19,CYP2C8,ALB,ATM,APOE,ABCB1
264	Hyperlipidemia, familial combined	C0020474	7	95	2.58297049295e-05	6.936416184971098e-05	APOA4,APOC3,APOA2,FN1,ALB,APOA1,APOE
265	Thickened skin	C0241165	14	339	2.70730733744e-05	6.962690488702049e-05	CHKB,KRT10,KRT14,KRT5,KRT16,SCN5A,KRT9,KRT13,TTN,DMD,KRT6A,LDB3,KRT1,KRT6B
266	Insulin resistance syndrome	C3714619	5	48	2.86943803961e-05	6.988964792433e-05	APOA4,APOC1,APOA2,APOC2,ALB
269	Plaque, Atherosclerotic	C0011389	11	226	3.01086363316e-05	7.067787703625853e-05	SERPING1,APOA4,CST3,GSN,ALB,TTR,APOA1,APOE,ABCC11,ABCC4,GFAP
270	Neuropathy ataxia retinitis pigmentosa syndrome	C0442874	12	265	3.23412674835e-05	7.094062007356805e-05	SERPING1,CYP3A4,CYP2C8,SACS,APOA2,GSN,ALB,SETX,LDB3,TTR,APOE,ABCB1
271	Extrahepatic cholestasis	C0005398	4	30	3.2591971016e-05	7.120336311087756e-05	SLC22A2,SLC22A1,ABCC2,ABCC3
272	Dyslipidemias	C0242339	11	228	3.28206084277e-05	7.146610614818708e-05	CYP3A4,HP,ABCC6,KRT16,AHSG,F7,APOC3,APOC2,APOA1,APOE,ABCB1
273	SUDDEN INFANT DEATH SYNDROME	C0038644	7	99	3.48443861021e-05	7.17288491854966e-05	SCN5A,CTSL,CYP2C19,ATM,RYR2,APOE,CYP2C9
274	 Cerebrovascular disease, occlusive (3)	C0007820	6	73	3.58755223613e-05	7.19915922228061e-05	APOA4,F7,APOC3,ITGA2,APOA1,APOE
282	Bleeding with minor or no trauma	C0019080	6	74	3.9203884787e-05	7.409353652128219e-05	F7,CYP2C19,ITGA2,APOE,CYP2C9,KRT1
283	Pseudoxanthoma elasticum	C0473583	5	51	4.08079465325e-05	7.43562795585917e-05	ABCC6,AHSG,CFH,APOE,ABCC1
284	Drug-Induced Liver Injury	C0860207	10	198	4.27235731352e-05	7.461902259590121e-05	CYP2C19,ABCC2,HPX,GSN,ALB,TTR,APOA1,APOE,CYP2C9,ABCB1
285	Oral leukoplakia	C0023532	6	75	4.27815414776e-05	7.488176563321072e-05	KRT14,KRT5,KRT16,KRT6A,ATM,KRT6B
286	Abnormality of circulating protein level	C4023679	12	274	4.56296856355e-05	7.514450867052024e-05	CHKB,TRAPPC11,NPHS1,SCN5A,TTN,DMD,FN1,ALB,SETX,SLC16A1,LDB3,ATM
287	Acute myocardial infarction	C0155626	11	237	4.78189627697e-05	7.540725170782976e-05	HP,ABCC6,CST3,F7,SCN5A,CYP2C19,DMD,ITGA2,APOA1,APOE,ABCB1
288	Alzheimer Disease, Late Onset	C0494463	6	77	5.07417725378e-05	7.566999474513926e-05	CST3,APOC1,TOMM40,APOC2,APOE,GFAP
289	Abnormality of the level of lipoprotein cholesterol	C4023615	4	33	5.26388562975e-05	7.593273778244876e-05	APOC3,SLC25A13,APOA1,APOE
290	Drug Allergy	C0013182	6	79	5.98758142111e-05	7.619548081975827e-05	CYP3A4,CYP2C19,CYP2C8,ABCC2,CYP2C9,ABCB1
291	Geographic Atrophy	C1536085	4	34	6.10864812659e-05	7.645822385706779e-05	DICER1,CFH,CFD,CFB
292	Cholelithiasis	C0008350	9	171	6.18455134689e-05	7.672096689437729e-05	APOA4,SLCO1A2,APOC1,APOC3,ABCC3,TTR,APOA1,APOE,FABP6
295	Azorean disease	C0024408	6	80	6.4922792089e-05	7.750919600630584e-05	CST3,BBC3,ATM,TTR,APOE,GFAP
302	Mild cognitive impairment	C1270972	8	141	7.3491720525e-05	7.93483972674724e-05	KRT14,CST3,DMD,TOMM40,APOC2,TTR,APOE,GFAP
303	Carotid Atherosclerosis	C0577631	7	111	7.89662759032e-05	7.961114030478192e-05	APOA4,HP,F7,APOC3,ITGA2,APOA1,APOE
